Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Repligen reported $33.53M in EBIT for its fiscal quarter ending in March of 2023.

Ebit Change
Agilent A:US USD 401M 37M
Align Technology ALGN:US USD 133.7M 9.59M
BioMarin Pharmaceutical BMRN:US USD 61.45M 85.95M
Bristol-Myers Squibb BMY:US USD 3B 686M
Bruker BRKR:US USD 126.2M 10.5M
Catalent CTLT:US USD 139M 81M
Charles River Laboratories CRL:US USD 168.96M 5.15M
Danaher DHR:US USD 1.77B 530M
Dentsply International XRAY:US USD 61M 11M
Exact Sciences EXAS:US USD -77022000 38.43M
General Electric GE:US USD 404M 1.12B
Henry Schein HSIC:US USD 205M 37M
Illumina ILMN:US USD -34000000 72M
IQVIA Holdings Inc IQV:US USD 512M 120M
Myriad Genetics MYGN:US USD -52200000 6.2M
NanoString Technologies NSTG:US USD -40550000 2.13M
OraSure Technologies OSUR:US USD 28.04M 14.75M
Pacific Biosciences Of California PACB:US USD -91252000 7.87M
Patterson Companies PDCO:US USD 75.92M 15.83M
Peregrine Pharmaceuticals PPHM:US USD 2.72M 5.4M
Pfizer PFE:US USD 6.91B 1.1B
Repligen RGEN:US USD 33.53M 295K
Thermo Fisher Scientific TMO:US USD 1.71B 215M
Waters WAT:US USD 174.17M 112.12M
West Pharmaceutical Services WST:US USD 168.1M 12.8M